By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoBio Corporation 

P.O. Box 8110

Ann Arbor  Michigan  48107  U.S.A.
Phone: 734-302-4000 Fax: 734-302-6150


Start Up

Company News
NanoBio Corporation's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine 9/23/2015 11:02:04 AM
NanoBio CorporationTo Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection 10/8/2014 8:52:09 AM
NanoBio Corporation's Intranasal Vaccine Demonstrates Robust Protection Against Herpes Simplex-2 Infection 4/28/2014 9:40:21 AM
Merck & Co., Inc. (MRK) Licenses NanoBio Corporation Technology 3/27/2014 9:33:37 AM
NanoBio Corporation Awarded Up to $10 Million in National Institutes of Health (NIH) Funding to Develop a Pandemic Influenza Vaccine 10/29/2013 11:26:48 AM
NanoBio Corporation; Interscience Conference on Antimicrobial Agents and Chemotherapy 9/11/2013 9:45:47 AM
NanoBio Corporation Closes $11 Million Series C Financing 11/28/2012 8:19:31 AM
NanoBio Corporation Announces Data Presentation on Its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012 10/15/2012 10:08:05 AM
NanoBio Corporation Promotes David Peralta to Chief Executive Officer 10/9/2012 8:28:16 AM
NanoBio Corporation to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium 9/24/2012 10:03:04 AM